Article
CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.
Cytometry. Part B, Clinical cytometry - 1 Mar 2018
Singleton B K, Ahmed M, Green C A, Heimpel H, Woźniak M J, Ranjha L, Seeney F, Bomford A, Mehta P, Guest A, Mushens R, King M-J
Abstract excerpt
BACKGROUND: Bone marrow examination has been the confirmatory test for congenital dyserythropoietic anemia type II (CDAII). Occasional spherocytes on peripheral blood smear can confound the diagnosis. Since a screening test is still unavailable, we explored the feasibility of using flow cytometry as a preliminary screening method. METHODS: Thirteen monoclonal antibodies with specificities for eight erythrocyte...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
